Unveiling Three SEHK Growth Companies With High Insider Ownership

In This Article:

As global markets navigate through varying economic signals, Hong Kong's Hang Seng Index has experienced a 1.5% decline amidst concerns over slowing economic growth and foreign selling pressures. In this context, identifying growth companies with high insider ownership in Hong Kong can offer investors potential resilience and alignment of interests between shareholders and management.

Top 10 Growth Companies With High Insider Ownership In Hong Kong

Name

Insider Ownership

Earnings Growth

iDreamSky Technology Holdings (SEHK:1119)

20.2%

104.1%

Fenbi (SEHK:2469)

32.6%

43%

Adicon Holdings (SEHK:9860)

22.4%

28.3%

Tian Tu Capital (SEHK:1973)

34%

70.5%

DPC Dash (SEHK:1405)

38.2%

90.2%

Zylox-Tonbridge Medical Technology (SEHK:2190)

18.7%

79.3%

Biocytogen Pharmaceuticals (Beijing) (SEHK:2315)

13.9%

100.1%

Ocumension Therapeutics (SEHK:1477)

23.1%

93.7%

Zhejiang Leapmotor Technology (SEHK:9863)

15%

76.5%

Beijing Airdoc Technology (SEHK:2251)

28.7%

83.9%

Click here to see the full list of 54 stocks from our Fast Growing SEHK Companies With High Insider Ownership screener.

Underneath we present a selection of stocks filtered out by our screen.

Xiamen Yan Palace Bird's Nest Industry

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Xiamen Yan Palace Bird's Nest Industry Co., Ltd. operates in the People’s Republic of China, focusing on the research, development, production, and marketing of edible bird’s nest products with a market capitalization of HK$4.52 billion.

Operations: The company generates revenue through various channels, including CN¥824.40 million from direct online customer sales, CN¥509.04 million from offline distributors, CN¥351.17 million from direct offline customer sales, and CN¥262.89 million from sales to e-commerce platforms.

Insider Ownership: 26.7%

Xiamen Yan Palace Bird's Nest Industry, a growth-oriented company in Hong Kong, demonstrates a robust insider ownership structure that aligns with its strategic interests. Recently affirming a dividend of RMB 2.15 per 10 shares, the company shows commitment to shareholder returns amidst modest revenue and earnings growth forecasts of 12.6% and 15.58% per year respectively. Despite not reaching high growth thresholds, its forecasted Return on Equity of 27.3% suggests efficient capital management compared to market benchmarks.